Support our Foundation of Myology project
1714 news items
The Institut de Myologie’s open-pace race, MyoRun, is celebrating its 20th edition!
On 09/10/2026
This year, the MyoRun open-pace race is celebrating its 20th edition and is offering two sporting and charitable events in aid of the 2026 Telethon!…
The diagnostic and pathophysiological challenges of toxic vacuolar myopathies
On 09/10/2026
Clinician and researchers from the Institute of Myology, in collaboration with international researchers, have investigated myopathies induced by chloroquine (and its derivatives, referred to by…
Muscle biopsy: a diagnostic technique that remains useful despite advances in genetics
On 08/10/2026
Italian researchers have examined the diagnostic value of muscle biopsy at a time when high-throughput sequencing (NGS) and immunoassays are increasingly relegating it to a…
Pompe disease: stabilisation of motor function two years after switching to avalglucosidase alfa
On 08/10/2026
A French study analysed real-world data from 47 adults with late-onset Pompe disease who switched to avalglucosidase alfa (Nexviadyme) after treatment failure with alglucosidase alfa…
A potential therapeutic benefit for DMD with the growth factor GDF5
On 08/10/2026
Researchers from the Center of Research in Myology* at the Institute have demonstrated the benefits of treatment with growth and differentiation factor 5 (GDF5) in…
Digestive problems: not to be underestimated in Steinert disease
On 07/10/2026
A study assessed the frequency of gastrointestinal symptoms and their burden in 95 patients with the adult-onset form of Steinert disease. The authors recommend incorporating…
MFM is now available as an app: pros and cons
On 07/10/2026
The teams in Lyon and Saint-Étienne, who designed and developed the Motor Function Measure (MFM), have announced that it is now available on a mobile…
Triple Burden: sexual health in the spotlight at WMS 2026 – Audrey El Kaïm winner of the WMS Allied Health Prize
On 06/10/2026
Presented in Hiroshima, the Triple Burden project received the WMS Allied Health Prize. This award recognises collaborative work examining the place of sexuality in research…
Eline Lemerle awarded the President’s Prize for Best Basic Science at the WMS 2026
On 06/10/2026
Eline Lemerle, a postdoctoral research fellow in the Muscle cell organisation and therapy for dominant centronuclear myopathy team headed by Marc Bitoun et Stéphane Vassilopoulos,…
Inflammatory myopathies: a new technology helping with diagnosis
On 06/10/2026
Plasma proteomics studies to assess the clinical manifestations and tissue damage associated with certain inflammatory myopathies An international consortium of researchers, including a French team,…
Intermittent positive pressure ventilation does indeed appear to have a positive effect on chest growth in children with type I SMA
On 06/10/2026
A French retrospective study assessed the effect of intermittent positive pressure ventilation (IPPV) using the Alpha 300® in seven children with type I spinal muscular…
Inflammatory myopathies: certain autoimmune conditions carry a significant risk of pulmonary complications
On 05/10/2026
Autoimmune conditions that test positive for anti-Ku antibodies carry a significant risk of pulmonary complications Clinicians from ten centres within the Assistance-Publique Hôpitaux de Paris (APHP) compiled and compared the clinical and laboratory data of 154 adults…
What CPK levels are genuinely pathological?
On 05/10/2026
British and Canadian researchers have sought to establish non-pathogenicity reference ranges for creatine phosphokinase (CPK) levels measured in routine clinical practice: According to the authors,…
Awards for two young researchers from the Institute at the WMS 2026 conference
On 03/10/2026
The 2026 World Muscle Society Congress, which took place from 29 September to 3 October 2026 in Hiroshima, Japan, brought together the international neuromuscular community…
Incorporating pool-based exercises into the management of Steinert disease
On 02/10/2026
In a Canadian study, 22 adults with Steinert’s disease (myotonic dystrophy type 1 or MD1) were randomised into groups for either aquatic or land-based training,…
Rare REDs-type diseases: the latest advances in sequencing
On 01/10/2026
The third workshop on long-read sequencing and diseases linked to the expansion of repetitive sequences (LRS & REDs) took place on 23 and 24 September…
Update to the national strategy for the genetic diagnosis of myopathies by Filnemus
On 01/10/2026
The French Rare Health Care for Neuromuscular Diseases Network (Filnemus) has published an update to its strategy for the genetic diagnosis of neuromuscular diseases, including…
Myasthenia gravis with anti-RACh+ antibodies: gefurulimab successfully completes Phase III trials
On 01/10/2026
The Phase III PREVAIL trial evaluated gefurulimab (or ALXN1720) against a placebo in 20 countries, including France, in 249 adults with a generalised form of…
Steinert disease: initial results from the Phase III trial of del-desiran
On 29/09/2026
In September 2026, Novartis announced the initial results of the Phase III HARBOR trial evaluating delpacibart andedesiran (del-desiran or AOC 1001) in type 1 myotonic…
The clinical application of a sequencing technique in Steinert disease-like disorders
On 28/09/2026
Researchers from the Center for Research in Myology, in collaboration with national and international researchers, have recently published a review on the clinical application of…
